U.S. Court of Appeals for the Federal Circuit
Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
This writing
- Type
- Opinion
- Author
- Alan David Lourie
- Filed
- Sept. 29, 2022
- Case
- Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.
- Case status
- Decided
Source The authoring judge was read from the signature line of the court's own published opinion.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 21-2121 Document: 49 Page: 1 Filed: 09/29/2022 United States Court of Appeals for the Federal Circuit ______________________ MYLAN PHARMACEUTICALS INC., Appellant v. MERCK SHARP & DOHME CORP., Appellee ______________________ 2021-2121 ______________________ Appeal from the United States Patent and Tra…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.